Cardiovascular

With spending on diagnostics alone for cardiovascular disease likely to be a major challenge for insurers amid the baby boom wave, Aetna is turning to an emerging option as part of a strategy to avoid invasive tests and treatments.

Gregory L. Fricchione, MD, of Harvard Medical School, says that patients suffering from non-communicable disease face a number of challenges.

Two articles in Evidence-Based Diabetes Management examine the relationships among stress, diabetes and the brain, and the growing body of research into yoga's positive effects on reducing stress and improving health.

For Peter Libby, MD, chief of cardiology at Brigham & Women's Hospital in Boston and professor of medicine at Harvard Medical School, the rewards of a life in clinical research outweigh the risks.

Should patients with moderately elevated levels of triglycerides be treated, even while cardiologists await the results of a trial that may provide a definitive answer?

The recent dispute over the accuracy of the cardiovascular risk calculator points up the power and limitations of "big data," as well as the need for a blueprint for health guidelines aimed at consumers.

A study to assess clinician attitudes and experiences after participating in a New York City cardiovascular disease focused quality recognition and financial incentive program using health information technology.

Hospitals will face growing pressure to reduce costs and improve outcomes as transparency programs reveal comparative performance.

Promoting domestic medical travel to high-quality providers could improve clinical outcomes and reduce long-term healthcare costs.